The Only Oral Drug for AIDS-Related Kaposi Sarcoma Has Been FDA Approved
source: pixabay.com

The Only Oral Drug for AIDS-Related Kaposi Sarcoma Has Been FDA Approved

  According to a recent article in Medscape, the FDA has issued accelerated approval for Bristol-Myers Squibb's Pomalyst (pomalidomide). Pomalyst was approved as the first new oral treatment for AIDS-related…

Continue Reading The Only Oral Drug for AIDS-Related Kaposi Sarcoma Has Been FDA Approved
Nucala Granted Priority Review as Possible Biologic Treatment For HES
source: pixabay.com

Nucala Granted Priority Review as Possible Biologic Treatment For HES

As reported in GSK, the FDA has just granted priority review to Nucala (mepolizumab), a targeted biological treatment to help patients with hypereosinophilic syndrome (HES). If the medication is accepted,…

Continue Reading Nucala Granted Priority Review as Possible Biologic Treatment For HES
Study: Ultomiris Resolves Complications of aHUS
Photo by Robina Weermeijer on Unsplash

Study: Ultomiris Resolves Complications of aHUS

Ultomiris, a product of Alexion Pharmaceuticals, has recently been studied in a Phase 3 clinical trial. This study was intended to ultomiris' effect on life-threatening complications of atypical hemolytic uremic…

Continue Reading Study: Ultomiris Resolves Complications of aHUS
Close Menu